Research trend of lung cancer epigenetics research: Bibliometric and visual analysis of top-100 cited documents

被引:1
作者
Lou, Wangzhouyang [1 ]
Li, Yunsheng [1 ]
机构
[1] Chunan Cty First Peoples Hosp, Hangzhou 311700, Peoples R China
关键词
Lung cancer; Epigenetics; DNA methylation; Non-coding RNA; Bibliometric analysis; DNA METHYLATION; ABERRANT METHYLATION; POOR-PROGNOSIS; NONCODING RNAS; MICRORNA; HYPERMETHYLATION; EXPRESSION; TUMOR; EPIDEMIOLOGY; P16(INK4A);
D O I
10.1016/j.heliyon.2024.e35686
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Lung cancer is a highly prevalent cancer on a global scale and its oncogenic process is driven by the accumulation of multiple pathological events. Epigenetics has gained significant recognition in recent years as a crucial contributor to the development of lung cancer. Epigenetics include processes such as DNA methylation, histone modification, chromatin remodeling, and RNA modification. These pathways lead to enduring alterations in genetic phenotypes, which are crucial in the advancement and growth of lung cancer. However, the specific mechanisms and roles of epigenetics in lung cancer still need to be further elucidated. Methods: We obtained publications from the Web of Science databases and applied a rigorous search method to filter them. Ultimately, we gathered high-quality publications that had received the highest 100 number of citations. The data were processed and visualized by various bibliometric tools. Results: The 100 papers had varying numbers of citations, with the lowest being 491 and the most being 6316. On average, each work received 1119 citations. A total of 1056 co-authors were involved in publishing these papers in 59 journals from 185 institutions in 27 countries. The majority of high-caliber research in the subject of lung cancer epigenetics is conducted in advanced countries, with the United States taking the lead in terms of both the quantity of articles produced and their academic influence. The study of DNA methylation has been a longstanding research priority in the discipline. With the development of next-generation sequencing technology in recent years, research related to non-coding RNA has become a research hotspot. Future research directions may focus more on exploring the mechanisms of action of messenger RNA and circular RNA and developing targeted treatment strategies based on non-coding RNA drugs. Conclusion: We analyzed 100 top lung cancer and epigenetics documents through various bibliometric analysis tools. This study provides a concise overview of the findings from prior research, anticipates future research directions, and offers potential avenues for additional investigation.
引用
收藏
页数:16
相关论文
共 78 条
[1]   Dynamic and static circulating cancer microRNA biomarkers - a validation study [J].
Abu-Halima, Masood ;
Keller, Andreas ;
Becker, Lea Simone ;
Fischer, Ulrike ;
Engel, Annika ;
Ludwig, Nicole ;
Kern, Fabian ;
Rounge, Trine B. ;
Langseth, Hilde ;
Meese, Eckart ;
Keller, Verena .
RNA BIOLOGY, 2023, 20 (01) :1-9
[2]   bibliometrix: An R-tool for comprehensive science mapping analysis [J].
Aria, Massimo ;
Cuccurullo, Corrado .
JOURNAL OF INFORMETRICS, 2017, 11 (04) :959-975
[3]   Lung Cancer 2020 Epidemiology, Etiology, and Prevention [J].
Bade, Brett C. ;
Dela Cruz, Charles S. .
CLINICS IN CHEST MEDICINE, 2020, 41 (01) :1-+
[4]  
Balgkouranidou I, 2013, BIOMARK MED, V7, P49, DOI [10.2217/BMM.12.111, 10.2217/bmm.12.111]
[5]   Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis [J].
Belinsky, SA ;
Nikula, KJ ;
Palmisano, WA ;
Michels, R ;
Saccomanno, G ;
Gabrielson, E ;
Baylin, SB ;
Herman, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11891-11896
[6]   Sizing up miRNAs as cancer genes [J].
Caldas, C ;
Brenton, JD .
NATURE MEDICINE, 2005, 11 (07) :712-714
[7]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[8]   miR-4739 promotes epithelial-mesenchymal transition and angiogenesis in "driver gene-negative" non-small cell lung cancer via activating the Wnt/β-catenin signaling [J].
Cen, Wenjian ;
Yan, Qin ;
Zhou, Wenpeng ;
Mao, Minjie ;
Huang, Qitao ;
Lin, Yaobin ;
Jiang, Neng .
CELLULAR ONCOLOGY, 2023, 46 (06) :1821-1835
[9]   Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer [J].
Ceppi, Paolo ;
Mudduluru, Giridhar ;
Kumarswamy, Regalla ;
Rapa, Ida ;
Scagliotti, Giorgio V. ;
Papotti, Mauro ;
Allgayer, Heike .
MOLECULAR CANCER RESEARCH, 2010, 8 (09) :1207-1216
[10]   MicroRNAs as oncogenes and tumor suppressors [J].
Chen, CZ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1768-1771